• News
  • SAN DIEGO
  • Finance

Optimer board to review strategic alternatives

Shares of Optimer Pharmaceuticals Inc. (Nasdaq: OPTR) jumped Wednesday on the possibility of a sale of the drug developer.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!